Correlation Between Crescita Therapeutics and Antisense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Crescita Therapeutics and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crescita Therapeutics and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crescita Therapeutics and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Crescita Therapeutics and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crescita Therapeutics with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crescita Therapeutics and Antisense Therapeutics.

Diversification Opportunities for Crescita Therapeutics and Antisense Therapeutics

0.81

Correlation Coefficient

Crescita Therapeutics  Antisense Therapeutics

Very poor diversification

The 3 months correlation between Crescita and Antisense is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Crescita Therapeutics and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Crescita Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crescita Therapeutics are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Crescita Therapeutics i.e., Crescita Therapeutics and Antisense Therapeutics go up and down completely randomly.

Pair Corralation between Crescita Therapeutics and Antisense Therapeutics

Assuming the 90 days horizon Crescita Therapeutics is expected to generate 0.1 times more return on investment than Antisense Therapeutics. However, Crescita Therapeutics is 9.94 times less risky than Antisense Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Antisense Therapeutics Limited is currently generating about -0.2 per unit of risk. If you would invest  45.00  in Crescita Therapeutics on October 20, 2024 and sell it today you would lose (6.00) from holding Crescita Therapeutics or give up 13.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	76.56%
Values	Daily Returns

Crescita Therapeutics  vs.  Antisense Therapeutics Limited

Crescita Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Crescita Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Antisense Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Antisense Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Crescita Therapeutics and Antisense Therapeutics

The main advantage of trading using opposite Crescita Therapeutics and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crescita Therapeutics position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.

The idea behind Crescita Therapeutics and Antisense Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.